BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  OncoPep Announces Initiation Of Phase 1b Clinical Trial Of PVX-410 In Smoldering Multiple Myeloma And Upcoming Presentation Of Positive Results From Phase 1/2a Clinical Trial At American Society of Hematology

  November 28, 2016

   · 

  3 min read
• SIME Dx Announces Validation Of First Test For Respiratory Distress Syndrome In Premature Infants

  November 28, 2016

   · 

  3 min read
• Drug Development

  GTx, Inc. Release: Enobosarm Meets Pre-Specified Primary Efficacy Endpoint In Ongoing Phase 2 Clinical Trial In ER+/AR+ Breast Cancer

  November 28, 2016

   · 

  8 min read
• Policy

  FDA Grants Priority Review To Merck & Co.’s Supplemental Biologics License Application (sBLA) Seeking Approval For KEYTRUDA (Pembrolizumab) For New Indication In Microsatellite Instability-High Cancer

  November 28, 2016

   · 

  15 min read
• Moberg Pharma AB (Formerly known as Moberg Derma) Receives Bondholders’ Approval For Increased Flexibility In Acquisition Financing

  November 28, 2016

   · 

  3 min read
• Drug Development

  Cidara’s Presentations At American Society of Hematology 2016 To Highlight Potential Role Of Novel Antifungal CD101 In Patients With Hematologic Malignancies

  November 28, 2016

   · 

  5 min read
• Drug Development

  Nature Cell Receives U.S. FDA Approval For Phase I And II Alzheimer’s Clinical Trial

  November 28, 2016

   · 

  2 min read
• Creo Medical Eyes £20 Million From Stock Market Flotation

  November 28, 2016

   · 

  1 min read
• Deals

  Macrocure Announces New Date For Special General Meeting Of Shareholders To Approve Merger With Leap Therapeutics

  November 28, 2016

   · 

  7 min read
• SYGNIS Reinforces Its Proteomics Portfolio With Two Patents Granted In Europe And China

  November 28, 2016

   · 

  1 min read